Dr Anirvan Ghosh named head of discovery for CNS at Roche
This article was originally published in Scrip
Executive Summary
Roche has named Dr Anirvan Ghosh head of discovery for central nervous system (CNS). He will oversee discovery research in the CNS Disease and Translational Area with an emphasis on disorders such as schizophrenia, neurodegeneration, treatment-resistant depression and neurodevelopment disorders. Dr Ghosh, who will relocate to Basel, Switzerland, joins Roche's Pharma Research and Early Development organisation from the University of California San Diego, where he has been the Stephen Kuffler professor of neurobiology since 2003; chair of the neurobiology section, division of biological sciences, since 2008; and co-director of the Center for Neural Circuits and Behavior since 2009.